Liu Ying

Dr. Liu Ying serves as a Research Assistant Professor in the Department of Biomedical Engineering at Southern University of Science and Technology (SUSTech), where she focuses on developing innovative diagnostic technologies. Her academic journey began at Zhengzhou University where she earned her Bachelor's degree in Chemistry, followed by a Ph.D. in Organic Chemistry from Peking University.

Her educational background includes:

• Ph.D. in Organic Chemistry, College of Chemistry and Molecular Engineering, Peking University (2011.09-2016.07)
• B.S. in Chemistry, College of Chemistry and Molecular Engineering, Zhengzhou University (2007.09-2011.06)

Dr. Liu's research spans multiple cutting-edge areas in biomedical diagnostics, with particular expertise in nucleic acid and protein detection methods. Her work bridges the gap between fundamental chemical principles and practical clinical applications, especially in liquid biopsy technologies. She has made significant contributions to the development of automated viral nucleic acid extraction technology that has received emergency authorization from the US FDA and been commercialized.

Her publication record demonstrates a consistent trajectory of impactful research, with papers appearing in high-impact journals such as Angewandte Chemie (IF=12.439) and Chemical Science (IF=9.322). Her work shows a clear evolution from fundamental chemical biology techniques to applied biomedical engineering solutions.

Her notable achievements include:

• General Financial Grant from China Postdoctoral Science Foundation (2020M672702)
• Special Financial Grant from China Postdoctoral Science Foundation (2020T130051ZX)
• Multiple prestigious scholarships including the Peking University President Scholarship and National Scholarship

Dr. Liu has received funding for significant research projects including 'Enrichment of fetal cell-free DNA from maternal plasma based on novel magnetic nanoparticles platform' and 'High throughput Covid-19 detection and diagnosis platform based on plasmonic gold microarray technology.' Her work demonstrates strong translational potential, with one technology already commercialized and FDA-authorized.